All Menu Shortcuts Main Contants Shortcuts

Faculty

Faculty Directory

Hwa Young CHOI

Name
Hwa Young CHOI
Faculty Appointment
(title, department)
Assistant Professor, Department of Cancer Control and Population Health
Area of Expertise
Infectious Disease Epidemiology, Data science
Contact no
031-920-2761
E-mail
hychoi@ncc.re.kr
Work Experience
Nov 2022 – Aug 2024: Postdoctoral Research Fellow, National Cancer Center
Aug 2021 – Oct 2022: Researcher, National Cancer Center
May 2014 – Jun 2021: Researcher, National Cancer Center
Educational Background
Sep 2017 – Aug 2022: Ph.D. Public health sciences, Hanyang University
Mar 2011 – Aug 2013: M.S. Statistics, Kyungpook National University
Mar 2006 – Feb 2011: B.S. Information Statistics, Andong National University
Research Interests
Public health, Infectious disease epidemiology, Health Economics
Achievements
- (2024) Prevalence, Incidence, and Treatment Pattern of Wilson’s Disease Using National Health Insurance Data From 2010-2020, Korea.

- (2023) Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study.

- (2023) Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019.

- (2022) Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study.

- (2022) A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective.

- (2022) Association between levels of physical activity and low handgrip strength: Korea National Health and Nutrition Examination Survey 2014-2019.

- (2021) Estimated incidence of juvenile-onset recurrent respiratory papillomatosis in South Korea.

- (2020) Comorbidities and Prescribed Medications in Korean Patients with Chronic Hepatitis C: A Nationwide, Population-Based Study.

- (2020) Association between viral hepatitis infection and Parkinson's disease: A population-based prospective study.

- (2019) Epidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017.

- (2019) The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015.

- (2019) Cost-effectiveness of sofosbuvir plus ribavirin therapy for hepatitis C virus genotype 2 infection in South Korea.

- (2019) Prevalence of human papillomavirus-related diseases in the Republic of Korea: a cross-sectional study.

- (2018) Health Behavior Associated Liver Enzymes among Obese Korean Adolescents, 2009-2014.

- (2018) Cost-effectiveness and health-related outcomes of screening for hepatitis C in Korean population.

- (2018) Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database.

- (2018) The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.

- (2017) Current status of hepatitis C virus infection and countermeasures in South Korea.

- (2017) Risk of diabetes in viral hepatitis B or C patients compared to that in non-infected individuals in Korea, 2002-2013: A population-based cohort study.

- (2017) Healthcare Costs for Chronic Hepatitis C in South Korea during 2009-2013: An Analysis of National Health Insurance Claims Data.

- (2017) Population-based Prevalence, Incidence, and Disease Burden of Autoimmune Hepatitis in South Korea.

- (2017) Nontuberculosis Mycobacterial Infections in Tuberculosis Specialized Treatment Center in republic of Korea.

- (2015) Incidence, prevalence and complications of Budd-Chiari syndrome in South Korea: a nationwide, population-based study.

- (2015) Population-based epidemiology of primary biliary cirrhosis in South Korea.

- (2015) Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012.

- (2015) Risk Factors for Hepatitis C Virus (HCV) Infection in Areas with a High Prevalence of HCV in the Republic of Korea in 2013.

- (2014) Prevalence of fungal infections using National Health Insurance data from 2009-2013, South Korea.